DrugPatentWatch Database Preview
PROMACTA KIT Drug Profile
When do Promacta Kit patents expire, and what generic alternatives are available?
Promacta Kit is a drug marketed by Novartis Pharms Corp and is included in one NDA. There are eight patents protecting this drug.
This drug has one hundred and thirty-four patent family members in thirty countries.
The generic ingredient in PROMACTA KIT is eltrombopag olamine. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the eltrombopag olamine profile page.
Summary for PROMACTA KIT
| International Patents: | 134 |
| US Patents: | 8 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Clinical Trials: | 27 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PROMACTA KIT at DailyMed |
US Patents and Regulatory Information for PROMACTA KIT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Pharms Corp | PROMACTA KIT | eltrombopag olamine | FOR SUSPENSION;ORAL | 207027-002 | Sep 27, 2018 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Novartis Pharms Corp | PROMACTA KIT | eltrombopag olamine | FOR SUSPENSION;ORAL | 207027-001 | Aug 24, 2015 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Novartis Pharms Corp | PROMACTA KIT | eltrombopag olamine | FOR SUSPENSION;ORAL | 207027-001 | Aug 24, 2015 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Novartis Pharms Corp | PROMACTA KIT | eltrombopag olamine | FOR SUSPENSION;ORAL | 207027-001 | Aug 24, 2015 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for PROMACTA KIT
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20040106569 | ➤ Try a Free Trial |
| China | 101343251 | ➤ Try a Free Trial |
| Israel | 199438 | ➤ Try a Free Trial |
| Denmark | 1864981 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for PROMACTA KIT
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1294378 | 388 | Finland | ➤ Try a Free Trial | |
| 1294378 | C300451 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: ELTROMBOPAG, DESGEWENST IN DE; REGISTRATION NO/DATE: EU/1/10/612/001-006 20100311 |
| 1294378 | 23/2010 | Austria | ➤ Try a Free Trial | PRODUCT NAME: ELTROMBOPAG, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, HYDRATS UND SOLVATS DAVON; REGISTRATION NO/DATE: EU/1/10/612/001-006 20100311 |
| 1534390 | C20100006 00032 | Estonia | ➤ Try a Free Trial | PRODUCT NAME: REVOLADE-ELTROMBOPAG; REG NO/DATE: C(2010)1662 11.03.2010 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
